How does cancer cover work on UK private medical insurance?

Full cancer cover funds diagnosis, treatment, radiotherapy, chemotherapy and licensed non-NICE-approved drugs with no cap. Core cancer cover restricts to NICE-approved treatments only — a £50,000+ gap on drugs like Enhertu. Bupa's Cancer Promise is the market-leading benefit and covers licensed drugs even when the NHS says no.

Key numbers

• Non-NICE drug cost per year: £50–£120k typical
• Bupa Cancer Promise cap: None
• Vitality cancer cover: Advanced (full)

Full cover versus core cover — the only distinction that matters

Every UK insurer sells cancer cover in two shapes. Full (sometimes 'advanced' or 'comprehensive') funds diagnosis, surgery, radiotherapy, chemotherapy, immunotherapy and licensed drugs that NICE has not approved, usually with no monetary cap and no time limit while treatment remains active. Core (sometimes 'essential' or 'NHS cancer support') funds NICE-approved treatment only, often with a time or monetary limit, and hands you back to the NHS beyond it. The premium difference is typically 12–18%. The claim difference can be £50,000 to £120,000 a year.

The drug gap in plain numbers

Licensed but non-NICE-funded oncology drugs run from about £50,000 to £120,000 a year. Trastuzumab deruxtecan for HER2-low breast cancer, several later-line immunotherapies and a number of targeted lung and renal agents fall in and out of NHS funding depending on indication and line of treatment. Full cancer cover is the only realistic way a UK household self-funds that gap.

What the pathway looks like on a claim

Suspected cancer is the fastest pathway in private medicine. Typical sequence on our desk: GP or private GP referral, consultant appointment within 2–5 days, imaging and biopsy within a week, multidisciplinary team decision within 10–14 days, treatment start inside three weeks. The NHS 62-day standard has not been met nationally for years, so the private route commonly saves four to six weeks at the diagnosis stage alone — the stage where time matters most.

Benefits people forget to check

Ask specifically about: reconstructive surgery after cancer treatment; wigs, prostheses and lymphoedema garments; genetic and genomic testing; stereotactic radiotherapy and proton beam referral; palliative and end-of-life care at home; and continuation of treatment after the policy would otherwise lapse. These are the clauses that separate a good cancer benefit from a marketing line.

Existing and historic cancer

Active cancer under treatment cannot be newly insured. Historic cancer, discharged and clear, is regularly placeable — five years clear is the usual comfort point, and the original site is often excluded while all other cover runs normally. If you already hold cover and a diagnosis arrives, do not switch insurer: CPME will not protect an open claim.

Cancer cover by insurer — what actually differs

Broker verdict

“If a client can only afford one upgrade, it is full cancer cover. Every other benefit is a convenience; this one is the reason PMI exists.” — , Head of Operations, PremierPMI

Related questions

Does PMI cover cancer screening?

Routine screening is generally excluded because it is not treatment of a diagnosed condition, though many plans include a health assessment or fund diagnostics once symptoms are present.

What happens if my treatment outlives my policy year?

Full cancer cover normally continues an active course of treatment through renewal. Core cover often stops at a time or monetary limit, which is the main reason to read the cap wording.

Can I mix NHS and private cancer treatment?

Yes, and it is common — NHS surgery with privately funded drugs, or private diagnostics followed by NHS treatment. Tell both teams so care is coordinated.

Is proton beam therapy covered?

Some insurers fund it, usually by referral abroad and only where clinically indicated. It is always worth asking the question explicitly rather than assuming.

PremierPMI is a UK private medical insurance broker specialising in whole-of-market placement across 10+ leading UK health insurers including Bupa, AXA Health, Aviva, Vitality, WPA, Freedom Health, The Exeter, General & Medical and National Friendly. FCA regulated (Tesha Family Ltd, FRN 1029667). Speak to a broker on 020 4525 0884, WhatsApp 020 8064 2273, or email contact@premierpmi.co.uk.